HomeBOVNF • OTCMKTS
add
BioInvent International AB
Previous close
$3.29
Year range
$3.29 - $3.29
Market cap
2.19B SEK
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.32M | -73.98% |
Operating expense | — | — |
Net income | -129.22M | -32.89% |
Net profit margin | -3.89K | -410.74% |
Earnings per share | — | — |
EBITDA | -128.79M | -25.88% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 690.46M | -27.33% |
Total assets | 785.82M | -27.74% |
Total liabilities | — | — |
Total equity | 683.02M | — |
Shares outstanding | 65.93M | — |
Price to book | 0.32 | — |
Return on assets | -39.24% | — |
Return on capital | -44.02% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -129.22M | -32.89% |
Cash from operations | -103.98M | -7.14% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | -60.58M | 23.03% |
About
Founded
1996
Website
Employees
122
